RPS RESEARCH NORWAY AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: BE
Barry Edward Balfe1978
Years since formation: 16 years; since May 25, 2009
Type: Limited company
VAT registered: Yes
Number of employees: 27

Ownership

Number of shares and share classes: 100,000; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2023: 35,169,889; NOK
Annual total result 2023: 1,037,352; NOK
Total equity 2023: 9,323,888; NOK

Last update: Nov 21, 2024

Management

Board

Name	Role	Shares
AH Andreas Granrud Helset 1975	Contact Person	-
JS John Sheahan 1978	Board Member	-
BE Barry Edward Balfe 1978	Chairman	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
E ECONPARTNER AS	Accountant	-
A AZETS INSIGHT AS	Accountant	-

Last update: Oct 16, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
PR Pharmaceutical Services Ne Research	Ordinary shares	100,000	100 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	35,169,889	26,590,801	20,682,062
Annual Total Result	1,037,352	1,231,210	1,048,563
Total assets	15,063,383	12,812,147	11,192,903
Total liabilities	5,739,496	4,525,608	4,137,574
Total equity	9,323,888	8,286,539	7,055,329

P&L

Year	2023	2022	2021
Total operating income	35,169,889	26,590,801	20,682,062
Total operating costs	32,945,974	24,731,827	19,419,776
Operating result	2,223,916	1,858,974	1,262,285
Financial income/costs	-874,852	-273,796	82,471
Profit before tax	1,349,064	1,585,177	1,344,756
Total tax & extraordinary income/cost	311,712	353,967	296,193
Annual Total Result	1,037,352	1,231,210	1,048,563

Balance overview

Year	2023	2022	2021
Total fixed assets	1,244	10,489	37,364
Total current assets	15,062,139	12,801,658	11,155,539
Total assets	15,063,383	12,812,147	11,192,903
Short term debt	4,393,610	3,311,302	3,090,316
Long term debt	1,345,885	1,214,306	1,047,257
Total liabilities	5,739,496	4,525,608	4,137,574
Contributed capital	100,000	100,000	100,000
Retained earnings	9,223,888	8,186,540	6,955,329
Total equity	9,323,888	8,286,539	7,055,329
Total equity and liabilities	15,063,383	12,812,147	11,192,903

RPS RESEARCH NORWAY AS994 115 405